Intervention News

Use of advanced thrombolysis in the U.S. remains low and is prone to disparate use among women and Black patients presenting with pulmonary embolism, a speaker reported.

ATLANTA — Among patients with lower socioeconomic status, interventions based on case management and financial incentives improved attendance at cardiac rehabilitation sessions, according to the results of the HeLP trial.

Gene therapy improved exercise capacity and blood flow and reduced chest pain occurrence and nitroglycerine use for patients with advanced ischemic heart disease, a speaker reported.

Patients not required to fast before cardiac catheterization reported higher overall postprocedural satisfaction with no periprocedural adverse events, a speaker reported.

ATLANTA — Intravascular ultrasound-guided PCI lowered risk for target vessel failure vs. an angiography-guided approach for patients with acute coronary syndrome, a speaker reported.

ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.

Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia.

ATLANTA — A home-based exercise intervention with protein supplementation improved physical performance at 12 weeks for older patients with frailty who underwent transcatheter aortic valve replacement, according to the PERFORM-TAVR trial.

Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.

DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American Academy of Neurology annual meeting.